Literature DB >> 2686736

A study of nerves containing peptides in the pulmonary vasculature of healthy infants and children and of those with pulmonary hypertension.

K M Allen1, J Wharton, J M Polak, S G Haworth.   

Abstract

Nerves containing peptides that supply the human intrapulmonary vasculature were studied in 21 controls aged one month to 24 years and in 13 patients with pulmonary hypertension aged 11 days to eight years. An indirect immunofluorescence technique was used to study the distribution and relative density of nerve fibres containing the general neuronal marker, protein gene product 9.5; tyrosine hydroxylase; synaptophysin; neuropeptide tyrosine; vasoactive intestinal polypeptide; substance P, somatostatin; and calcitonin gene related peptide. At all ages in normal and hypertensive lungs neuropeptide tyrosine was the predominant neuropeptide associated with the pulmonary vascular nerves. In normal lungs the relative density of nerve fibres increased during childhood only in the arteries of the respiratory unit. Pulmonary hypertension was associated with the premature innervation of these arteries during the first year of life. Innervation of small, abnormally thick-walled pre-capillary vessels by predominantly vasoconstrictor nerves may help to explain the susceptibility of infants to pulmonary hypertensive crises.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686736      PMCID: PMC1224833          DOI: 10.1136/hrt.62.5.353

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  28 in total

1.  Dedifferentiation, redifferentiation and bundle formation of smooth muscle cells in tissue culture: the influence of cell number and nerve fibres.

Authors:  J H Chamley; G R Campbell; G Burnstock
Journal:  J Embryol Exp Morphol       Date:  1974-10

2.  Pulmonary vascular development: normal values of peripheral vascular structure.

Authors:  S G Haworth; A A Hislop
Journal:  Am J Cardiol       Date:  1983-09-01       Impact factor: 2.778

3.  Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects.

Authors:  R D Dey; W A Shannon; S I Said
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

4.  Vasoactive effects of substance P on isolated rabbit pulmonary artery.

Authors:  D T Tanaka; M M Grunstein
Journal:  J Appl Physiol (1985)       Date:  1985-04

5.  Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.

Authors:  E Ekblad; L Edvinsson; C Wahlestedt; R Uddman; R Håkanson; F Sundler
Journal:  Regul Pept       Date:  1984-04

6.  Neuropeptide tyrosine (NPY): a newly discovered peptide is present in the mammalian respiratory tract.

Authors:  M N Sheppard; J M Polak; J M Allen; S R Bloom
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

7.  Comparative morphologic features of the pulmonary vasculature in mammals.

Authors:  J M Kay
Journal:  Am Rev Respir Dis       Date:  1983-08

8.  Cholinergic innervation of the human pulmonary circulation.

Authors:  F Amenta; C Cavallotti; F Ferrante; F Tonelli
Journal:  Acta Anat (Basel)       Date:  1983

9.  Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles.

Authors:  B Wiedenmann; W W Franke
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

10.  Cytoskeletal features of immature pulmonary vascular smooth muscle cells: the influence of pulmonary hypertension on normal development.

Authors:  K M Allen; S G Haworth
Journal:  J Pathol       Date:  1989-08       Impact factor: 7.996

View more
  10 in total

1.  Endothelium-dependent relaxation followed by contraction mediated by NK(1) receptors in precontracted rabbit intrapulmonary arteries.

Authors:  H Shirahase; M Kanda; K Kurahashi; S Nakamura
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Fatal persistent pulmonary hypertension presenting late in the neonatal period.

Authors:  J Raine; A A Hislop; A N Redington; S G Haworth; E A Shinebourne
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 3.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

4.  Endothelium-dependent contraction in intrapulmonary arteries: mediation by endothelial NK1 receptors and TXA2.

Authors:  H Shirahase; M Kanda; K Kurahashi; S Nakamura; H Usui; Y Shimizu
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

5.  Increased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy.

Authors:  M R MacLean; I Morecroft
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.

Authors:  S Crnkovic; B Egemnazarov; P Jain; U Seay; N Gattinger; L M Marsh; Z Bálint; G Kovacs; B Ghanim; W Klepetko; R T Schermuly; N Weissmann; A Olschewski; G Kwapiszewska
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 7.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

8.  Distribution of SP- and CGRP-like immunoreactive nerve fibers in the lower respiratory tract of neonatal foals: evidence for loss during development.

Authors:  I M Sonea; R M Bowker; N E Robinson; R E Holland
Journal:  Anat Embryol (Berl)       Date:  1994-11

9.  Ultrastructural localization of nitric oxide synthase and endothelin in coronary and pulmonary arteries of newborn rats.

Authors:  A Loesch; G Burnstock
Journal:  Cell Tissue Res       Date:  1995-03       Impact factor: 5.249

Review 10.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.